thenextweb
Novartis buys UK biotech Myricx for up to $1.5bn to chase a new cancer-drug class

Novartis has agreed to buy Myricx Bio, a small British oncology company, for up to $1.5bn, adding an early-stage but potentially significant technology to a cancer pipeline the industry keeps racing to expand. The Swiss group will pay $1.1bn upfront, with up to $400m more tied to milestones, in a deal that fits the pattern […]<br /> This story continues at The Next Web [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
FDA approves at-home pap smear alternative device for cervical cancer screening

The Food and Drug Administration has approved a new device called the Teal Wand, which its creator describes as an "at-home vaginal sample self-collection device for cervical cancer screening.&qu [...]

Match Score: 88.14

thenextweb
Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years

Akeso, the Chinese biotechnology company whose drug ivonescimab was dubbed “biotech’s DeepSeek moment” last year, has reported phase three clinical trial results showing a 34% reduction in the r [...]

Match Score: 71.22

qz
Novartis is buying a U.K. cancer drug startup for up to $1.5 billion

The Swiss drugmaker will pay $1.1 billion upfront and up to $400 million in milestones to gain a novel antibody-drug conjugate payload platform [...]

Match Score: 67.21

venturebeat
LangChain's CEO argues that better models alone won't get your AI agent to production

As models get smarter and more capable, the "harnesses" around them must also evolve. <br /> <br /> This "harness engineering" is an extension of context engineering, [...]

Match Score: 51.01

Destination
JPMorgan Chase is taking over the Apple Card

Apple announced today JPMorgan Chase will be the new issuer for the Apple Card. The official news arrived shortly after The Wall Street Journal reported that the two businesses had reached a deal rega [...]

Match Score: 41.83

venturebeat
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]

Match Score: 41.58

thenextweb
AI video startup Higgsfield is in talks to raise at a $5bn valuation

Higgsfield AI did not exist before March 2025. Fifteen months on, the video startup is in talks to raise money at a $5bn valuation, four times its worth at the start of the year. The company is seekin [...]

Match Score: 41.25

venturebeat
OpenAI's acquisition of OpenClaw signals the beginning of the end of the ChatGPT era

The chatbot era may have just received its obituary. Peter Steinberger, the creator of OpenClaw — the open-source AI agent that took the developer world by storm over the past month, raising concern [...]

Match Score: 40.80

Destination
Awesome Games Done Quick raises another $2.5 million for a cancer nonprofit

The weeklong speedrunning marathon Awesome Games Done Quick 2025 wrapped up in the wee hours of Sunday morning, and organizers say it managed to pull in a total of $2,556,305 for Prevent Cancer Founda [...]

Match Score: 39.65